SCHEMBL30120142

SCHEMBL30120142

CC(CC1CCN(C(=O)OC(C)(C)C)CC1)Cn1cnc2ccc(O)cc2c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR1 Q9BXC0 1/20 0.41
USP7 Q93009 2/20 0.40
GPR119 Q8TDV5 4/20 0.39
TGFBR1 P36897 1/20 0.39
KDM4E B2RXH2 1/20 0.38
PKM P14618 1/20 0.38
CHEK2 O96017 2/20 0.38
MCL1 Q07820 1/20 0.38
PIK3CD O00329 2/20 0.37
PIK3CA P42336 2/20 0.37
PIK3CB P42338 2/20 0.37
PIK3CG P48736 2/20 0.37
YAP1 P46937 2/20 0.37
FAAH O00519 1/20 0.37
CLK2 P49760 1/20 0.37
CLK3 P49761 1/20 0.37
GSK3B P49841 1/20 0.37
DYRK1A Q13627 1/20 0.37
DYRK2 Q92630 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24752951 1.00 HCAR1 (0.41) HCAR1USP7GPR119TGFBR1KDM4E
SCHEMBL31548396 0.87 USP7 (0.50) HCAR1USP7GPR119TGFBR1KDM4E
SCHEMBL24542863 0.86 ACHE (0.46) HCAR1USP7GPR119TGFBR1KDM4E
SCHEMBL30120002 0.82 GPR119 (0.42) HCAR1USP7GPR119MCL1PIK3CD
SCHEMBL24752971 0.82 GPR119 (0.42) HCAR1USP7GPR119MCL1PIK3CD
SCHEMBL24753270 0.81 HCAR1 (0.41) HCAR1GPR119TGFBR1KDM4EPKM
SCHEMBL30120095 0.81 HCAR1 (0.41) HCAR1GPR119TGFBR1KDM4EPKM
SCHEMBL24752953 0.81 BRAF (0.42) GPR119CHEK2
SCHEMBL30120463 0.81 BRAF (0.42) GPR119CHEK2
SCHEMBL24542757 0.79 IDO1 (0.44) HCAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4351583-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 Therapeutics, Inc. (US) 2024-04-17 EP disclosed
WO-2022261250-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 THERAPEUTICS, INC. (US) 2022-12-15 WO disclosed